Logo image of ALNXT.PA

NEXTEDIA (ALNXT.PA) Stock Fundamental Analysis

EPA:ALNXT - Euronext Paris - Matif - FR0004171346 - Common Stock - Currency: EUR

0.598  +0.01 (+2.4%)

Fundamental Rating

3

ALNXT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 74 industry peers in the IT Services industry. Both the profitability and financial health of ALNXT have multiple concerns. ALNXT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALNXT had positive earnings in the past year.
ALNXT had a negative operating cash flow in the past year.
Each year in the past 5 years ALNXT has been profitable.
In multiple years ALNXT reported negative operating cash flow during the last 5 years.
ALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M 8M

1.2 Ratios

ALNXT has a worse Return On Assets (1.93%) than 60.81% of its industry peers.
Looking at the Return On Equity, with a value of 3.72%, ALNXT is doing worse than 63.51% of the companies in the same industry.
ALNXT has a Return On Invested Capital of 6.48%. This is comparable to the rest of the industry: ALNXT outperforms 41.89% of its industry peers.
ALNXT had an Average Return On Invested Capital over the past 3 years of 7.12%. This is below the industry average of 11.05%.
Industry RankSector Rank
ROA 1.93%
ROE 3.72%
ROIC 6.48%
ROA(3y)2.7%
ROA(5y)3.1%
ROE(3y)5.7%
ROE(5y)6.55%
ROIC(3y)7.12%
ROIC(5y)6.83%
ALNXT.PA Yearly ROA, ROE, ROICALNXT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 -60

1.3 Margins

ALNXT has a Profit Margin (1.75%) which is in line with its industry peers.
In the last couple of years the Profit Margin of ALNXT has declined.
ALNXT has a Operating Margin (4.79%) which is in line with its industry peers.
ALNXT's Operating Margin has declined in the last couple of years.
The Gross Margin of ALNXT (58.27%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ALNXT has declined.
Industry RankSector Rank
OM 4.79%
PM (TTM) 1.75%
GM 58.27%
OM growth 3Y-9.85%
OM growth 5Y-11.86%
PM growth 3Y-55.35%
PM growth 5Y-33.92%
GM growth 3Y-13.35%
GM growth 5Y-9.62%
ALNXT.PA Yearly Profit, Operating, Gross MarginsALNXT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

3

2. Health

2.1 Basic Checks

ALNXT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ALNXT remains at a similar level compared to 1 year ago.
ALNXT has more shares outstanding than it did 5 years ago.
ALNXT has a worse debt/assets ratio than last year.
ALNXT.PA Yearly Shares OutstandingALNXT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
ALNXT.PA Yearly Total Debt VS Total AssetsALNXT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

ALNXT has an Altman-Z score of 2.10. This is not the best score and indicates that ALNXT is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.10, ALNXT perfoms like the industry average, outperforming 40.54% of the companies in the same industry.
A Debt/Equity ratio of 0.19 indicates that ALNXT is not too dependend on debt financing.
ALNXT has a better Debt to Equity ratio (0.19) than 77.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 2.1
ROIC/WACC0.94
WACC6.93%
ALNXT.PA Yearly LT Debt VS Equity VS FCFALNXT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M

2.3 Liquidity

ALNXT has a Current Ratio of 1.18. This is a normal value and indicates that ALNXT is financially healthy and should not expect problems in meeting its short term obligations.
ALNXT has a Current ratio of 1.18. This is comparable to the rest of the industry: ALNXT outperforms 44.59% of its industry peers.
ALNXT has a Quick Ratio of 1.18. This is a normal value and indicates that ALNXT is financially healthy and should not expect problems in meeting its short term obligations.
ALNXT's Quick ratio of 1.18 is in line compared to the rest of the industry. ALNXT outperforms 51.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
ALNXT.PA Yearly Current Assets VS Current LiabilitesALNXT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

5

3. Growth

3.1 Past

The earnings per share for ALNXT have decreased strongly by -10.69% in the last year.
The earnings per share for ALNXT have been decreasing by -29.97% on average. This is quite bad
ALNXT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.86%.
The Revenue has been growing by 21.91% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-10.69%
EPS 3Y-43.15%
EPS 5Y-29.97%
EPS Q2Q%2300%
Revenue 1Y (TTM)11.86%
Revenue growth 3Y32.39%
Revenue growth 5Y21.91%
Sales Q2Q%10.33%

3.2 Future

Based on estimates for the next years, ALNXT will show a small growth in Earnings Per Share. The EPS will grow by 6.22% on average per year.
The Revenue is expected to grow by 8.14% on average over the next years. This is quite good.
EPS Next Y0%
EPS Next 2Y9.84%
EPS Next 3Y6.22%
EPS Next 5YN/A
Revenue Next Year8.06%
Revenue Next 2Y10.93%
Revenue Next 3Y8.14%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALNXT.PA Yearly Revenue VS EstimatesALNXT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALNXT.PA Yearly EPS VS EstimatesALNXT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.93, which indicates a rather expensive current valuation of ALNXT.
Based on the Price/Earnings ratio, ALNXT is valued a bit cheaper than the industry average as 60.81% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.32, ALNXT is valued a bit cheaper.
With a Price/Forward Earnings ratio of 6.41, the valuation of ALNXT can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALNXT indicates a rather cheap valuation: ALNXT is cheaper than 94.59% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.19. ALNXT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 19.93
Fwd PE 6.41
ALNXT.PA Price Earnings VS Forward Price EarningsALNXT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALNXT.PA Per share dataALNXT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.84%
EPS Next 3Y6.22%

0

5. Dividend

5.1 Amount

ALNXT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NEXTEDIA

EPA:ALNXT (6/17/2025, 7:00:00 PM)

0.598

+0.01 (+2.4%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners17.68%
Ins Owner ChangeN/A
Market Cap23.33M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.93
Fwd PE 6.41
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.78
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.03
EY5.02%
EPS(NY)0.09
Fwd EY15.61%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS1.63
BVpS0.76
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.93%
ROE 3.72%
ROCE 8.47%
ROIC 6.48%
ROICexc 8.11%
ROICexgc N/A
OM 4.79%
PM (TTM) 1.75%
GM 58.27%
FCFM N/A
ROA(3y)2.7%
ROA(5y)3.1%
ROE(3y)5.7%
ROE(5y)6.55%
ROIC(3y)7.12%
ROIC(5y)6.83%
ROICexc(3y)9.7%
ROICexc(5y)9.09%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.3%
ROCE(5y)9.03%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y0.88%
ROICexc growth 5Y-12.19%
OM growth 3Y-9.85%
OM growth 5Y-11.86%
PM growth 3Y-55.35%
PM growth 5Y-33.92%
GM growth 3Y-13.35%
GM growth 5Y-9.62%
F-Score5
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z 2.1
F-Score5
WACC6.93%
ROIC/WACC0.94
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.48%
Cap/Sales(5y)0.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.69%
EPS 3Y-43.15%
EPS 5Y-29.97%
EPS Q2Q%2300%
EPS Next Y0%
EPS Next 2Y9.84%
EPS Next 3Y6.22%
EPS Next 5YN/A
Revenue 1Y (TTM)11.86%
Revenue growth 3Y32.39%
Revenue growth 5Y21.91%
Sales Q2Q%10.33%
Revenue Next Year8.06%
Revenue Next 2Y10.93%
Revenue Next 3Y8.14%
Revenue Next 5YN/A
EBIT growth 1Y42.44%
EBIT growth 3Y19.35%
EBIT growth 5Y7.45%
EBIT Next Year24.99%
EBIT Next 3Y11.05%
EBIT Next 5YN/A
FCF growth 1Y55.48%
FCF growth 3Y-23.51%
FCF growth 5Y26.26%
OCF growth 1Y71.37%
OCF growth 3Y-19.97%
OCF growth 5Y23.79%